DK0925789T4 - Anvendelse af azithromycin ved topisk behandling af öjeninfektioner - Google Patents

Anvendelse af azithromycin ved topisk behandling af öjeninfektioner

Info

Publication number
DK0925789T4
DK0925789T4 DK98309274T DK98309274T DK0925789T4 DK 0925789 T4 DK0925789 T4 DK 0925789T4 DK 98309274 T DK98309274 T DK 98309274T DK 98309274 T DK98309274 T DK 98309274T DK 0925789 T4 DK0925789 T4 DK 0925789T4
Authority
DK
Denmark
Prior art keywords
azithromycin
topical treatment
eye infections
treatment
infections
Prior art date
Application number
DK98309274T
Other languages
Danish (da)
English (en)
Other versions
DK0925789T3 (da
Inventor
Imran Ahmed
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22074743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0925789(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of DK0925789T3 publication Critical patent/DK0925789T3/da
Application granted granted Critical
Publication of DK0925789T4 publication Critical patent/DK0925789T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DK98309274T 1997-12-02 1998-11-12 Anvendelse af azithromycin ved topisk behandling af öjeninfektioner DK0925789T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6725097P 1997-12-02 1997-12-02

Publications (2)

Publication Number Publication Date
DK0925789T3 DK0925789T3 (da) 2004-10-25
DK0925789T4 true DK0925789T4 (da) 2009-07-13

Family

ID=22074743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98309274T DK0925789T4 (da) 1997-12-02 1998-11-12 Anvendelse af azithromycin ved topisk behandling af öjeninfektioner

Country Status (11)

Country Link
EP (1) EP0925789B2 (es)
JP (1) JPH11240838A (es)
AT (1) ATE271390T1 (es)
BR (1) BR9805318A (es)
CA (1) CA2254682C (es)
CY (1) CY1105482T1 (es)
DE (1) DE69825128T3 (es)
DK (1) DK0925789T4 (es)
ES (1) ES2221127T5 (es)
MX (1) MX232591B (es)
PT (1) PT925789E (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
DE10006560A1 (de) 2000-02-15 2001-08-23 Disetronic Licensing Ag Zweikomponentiger Kolbenstopfen
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
EP1563850A3 (en) * 2000-02-23 2008-02-20 Pfizer Products Inc. Method of increasing the bioavailability and tissue penetration of azithromycin
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
EP1652851A1 (en) 2001-05-22 2006-05-03 Pfizer Products Inc. New crystal form of Azithromycin
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
PL1691787T3 (pl) 2003-12-04 2008-11-28 Pfizer Prod Inc Sposób wytwarzania farmaceutycznych systemów wielocząstkowych
BRPI0416534A (pt) 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
KR101130252B1 (ko) 2004-07-02 2012-03-26 와카모토 세이야꾸 가부시끼가이샤 아지스로마이신 함유 수성 의약 조성물 및 그 조제 방법
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
WO2007074904A1 (ja) * 2005-12-28 2007-07-05 Wakamoto Pharmaceutical Co., Ltd. 水性医薬組成物
US20100247666A1 (en) * 2009-03-24 2010-09-30 Macleod Steven K Method for Preparing Suspensions of Low-Solubility Materials
US9775802B2 (en) 2009-03-24 2017-10-03 Bausch & Lomb Incorporated Method for preparing suspensions of low-solubility materials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
JPH09503504A (ja) * 1993-10-01 1997-04-08 ザ、プロクター、エンド、ギャンブル、カンパニー 成人歯周炎の治療のためのアジトロマイシンの用途とこの用途のための局所組成物
US5610198A (en) † 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases
AU4399396A (en) * 1994-12-19 1996-07-10 Russinsky Limited Compounds
US5872104A (en) * 1994-12-27 1999-02-16 Oridigm Corporation Combinations and methods for reducing antimicrobial resistance
WO1996039995A1 (en) † 1995-06-07 1996-12-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system

Also Published As

Publication number Publication date
DE69825128T3 (de) 2010-05-06
ES2221127T3 (es) 2004-12-16
DE69825128D1 (de) 2004-08-26
EP0925789B1 (en) 2004-07-21
ES2221127T5 (es) 2009-11-10
CY1105482T1 (el) 2010-04-28
ATE271390T1 (de) 2004-08-15
DK0925789T3 (da) 2004-10-25
DE69825128T2 (de) 2005-07-28
JPH11240838A (ja) 1999-09-07
EP0925789B2 (en) 2009-06-17
CA2254682C (en) 2003-07-08
PT925789E (pt) 2004-10-29
MX232591B (es) 2005-12-02
CA2254682A1 (en) 1999-06-02
BR9805318A (pt) 2000-04-11
EP0925789A1 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
DK0925789T3 (da) Anvendelse af azithromycin ved topisk behandling af öjeninfektioner
PT1075837E (pt) Processo de preparacao de formulacoes aquosas para utilizacao oftalmicas
DK2301541T3 (da) Antibiotiske sammensætninger til behandling af øjet
DE69309188D1 (de) Zusammensetzung für Okularlensen
PE14199A1 (es) Agonistas de 5-ht1f
BR9710993A (pt) Derivados anticonvulsivos úteis no tratamento de esclerose lateral amiotrófica (als)
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
BR0015257A (pt) Ente de contato útil para evitar olho seco
DK0788513T3 (da) Anvendelse af bindingsmidler for CD23 i behandlingen af atoimmune sygdomme
DK0869949T3 (da) Benzoxaziner som antimikrobielle midler
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
DE69520998D1 (de) Faserbehandlungszusammensetzungen
NO20003786D0 (no) Oftalmisk sammensetning
FR2731007B1 (fr) Composition de polyorganosiloxanes reticulables
ID25478A (id) Agonis 5-ht1f
PT1069885E (pt) Solucao oftalmica que compreende glicogenio
DE69307740D1 (de) Zusammensetzung für Okularlinsen
BR9813634A (pt) "abridores de canal de potássio"
DE69620313D1 (de) Als antimikrobielles Mittel verwendbare Zusammensetzung
ATE241640T1 (de) Fusidinsäure-derivate
DK1445641T3 (da) Okulære linser
DK0412941T3 (da) Phospholipider til behandling af dissemineret sklerose
DE29904366U1 (de) Brillenträger-Okular
SI1096934T1 (sl) Oksazolidinoni za zdravljenje ocesnih infekcij